Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis.
Rabitsch W, Bojic M, Wohlfarth P, Leiner M, Schörgenhofer C, Kalhs P, Schulenburg A, Sillaber C, Mitterbauer M, Sperr WR, Jäger U, Skrabs K, Greinix H, Hermann A, Lamm W.
Rabitsch W, et al. Among authors: leiner m.
J Cancer Res Clin Oncol. 2016 Jun;142(6):1307-14. doi: 10.1007/s00432-016-2134-3. Epub 2016 Feb 26.
J Cancer Res Clin Oncol. 2016.
PMID: 26920356
Free PMC article.